Lam Research (NASDAQ:LRCX) Shares Down 6.2% – What’s Next?

Lam Research Corporation (NASDAQ:LRCX)’s stock price fell 6.2% during mid-day trading on Thursday . The stock traded as low as $138.30 and last traded at $139.59. 13,498,962 shares were traded during trading, an increase of 14% from the average session volume of 11,848,491 shares. The stock had previously closed at $148.80.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on LRCX shares. Raymond James Financial boosted their price objective on shares of Lam Research from $90.00 to $110.00 and gave the stock an “outperform” rating in a research report on Thursday, July 31st. Summit Insights lowered shares of Lam Research from a “buy” rating to a “hold” rating in a research report on Thursday, July 31st. Wall Street Zen downgraded Lam Research from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Mizuho boosted their target price on shares of Lam Research from $162.00 to $170.00 and gave the company an “outperform” rating in a research note on Thursday, October 23rd. Finally, BNP Paribas Exane raised their price target on shares of Lam Research from $80.00 to $140.00 and gave the stock a “neutral” rating in a research note on Thursday, October 23rd. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $151.84.

Lam Research Trading Up 2.2%

The firm has a market capitalization of $179.17 billion, a price-to-earnings ratio of 31.42, a PEG ratio of 1.68 and a beta of 1.87. The business’s 50-day moving average price is $144.17 and its 200 day moving average price is $111.89. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.04. The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The firm’s quarterly revenue was up 27.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, equities analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd will be paid a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Wednesday, December 3rd. Lam Research’s dividend payout ratio (DPR) is 22.91%.

Insiders Place Their Bets

In other news, CFO Douglas R. Bettinger sold 40,080 shares of the company’s stock in a transaction dated Friday, November 14th. The shares were sold at an average price of $150.60, for a total value of $6,036,048.00. Following the sale, the chief financial officer owned 987,237 shares in the company, valued at approximately $148,677,892.20. This represents a 3.90% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Bethany Mayer sold 1,298 shares of the company’s stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total value of $207,667.02. Following the sale, the director directly owned 1,652 shares in the company, valued at approximately $264,303.48. This represents a 44.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 102,608 shares of company stock valued at $14,916,496. Corporate insiders own 0.31% of the company’s stock.

Institutional Trading of Lam Research

Institutional investors have recently added to or reduced their stakes in the business. IMG Wealth Management Inc. bought a new position in Lam Research in the second quarter worth about $26,000. Stance Capital LLC bought a new position in shares of Lam Research during the third quarter worth about $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Lam Research in the 2nd quarter worth about $27,000. Triumph Capital Management acquired a new stake in shares of Lam Research in the 3rd quarter worth about $27,000. Finally, Strategic Wealth Investment Group LLC bought a new stake in Lam Research in the 2nd quarter valued at about $29,000. Institutional investors own 84.61% of the company’s stock.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.